[1]: https://en.wikipedia.org/wiki/V(D)J_recombination "V(D)J recombination"
So, in a way, different individuals have different immune strategies. For example, super-responders to HIV tend to be HLA-B57. This HLA "version" trades better response to virus that mutate quickly for more chances of autoimmunity as thymic selection is less stringent (because HLA-B57 presents less selfpeptides in the thymus).
That is exactly how lymphomas originate.
If you sum these two up they end on top respectively in that order. Albeit prostate cancer is really close.
It's an artifact of grouping used. For colorectal for example, adenomas and carcinomas are lumped for a change.
Prostate is the second most common worldwide, or skin cancer, depending on year. The big 5 are over 1.5 million. (WCRF data. They lump all lung cancers but split immune system and skin cancers. For reasons? Bladder and lung cancer incidence is highly dependent on factors such as smoking and specific chemicals used in manufacturing. Potentially the same with colorectal and diet. Rates for breast and prostate are high because they're easy to spot and well tested. So per country data varies a lot.)
phrased another way: could the same process that spawns these legions of B cells also inadvertently spawn cancer cells?
related: healthy cells exhibit properties that allow them to go ignored by the immune system, similar to a VIP pass for bypassing security at a basketball game. is this right? if yes, what are the minimal properties that constitute this cellular VIP pass?
thanks for your help.
Cancer cells typically have mutations, even just single base pair changes, which change the way that genes are expressed in the cell and thereby influence such behavior.
The original functions of the B cell aren't necessarily needed for other cell types to exhibit similar functions. The base plan is there, it just needs a nudge.
> For the first half of the twentieth century, the going theory was that the invading element—the “antigen”—served as a template around which a corresponding antibody was molded. Only in 1955 did scientists discover the much stranger truth. It turned out that the cells that produce antibodies—called B cells, because they were first discovered in the bursa of Fabricius, an organ that does for birds what bone marrow does for humans—can produce only one kind each. Its structure is random, and nearly every B cell is discarded unused. If, however, an antibody created by a B cell happens to match some part of an antigen, that B cell will not just survive but clone itself. The clone incorporates many mutations, which offer the possibility of an even better match. After a few generations, an antibody with the best fit is “constructed” through a process of mini-evolution that occurs continuously in our lymph nodes and spleen. (Our ancestors the bony fish adapted the machinery of the B-cell system from an even more ancient parasite.)
So, natural selection discovered a way to run an embedded natural selection search process in an individual. Talk about meta.